Corrected QT (QTc) Study With Flucticasone Furoate and GW642444
Clinical trial NCT01209026 · COMPLETED
Trial details
- NCT number
- NCT01209026
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-23
- Primary completion
- 2011-01-04
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.